BERZIGOTTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 2.982
AS - Asia 2.012
EU - Europa 1.907
SA - Sud America 160
AF - Africa 137
OC - Oceania 4
Totale 7.202
Nazione #
US - Stati Uniti d'America 2.959
SG - Singapore 646
CN - Cina 603
GB - Regno Unito 443
VN - Vietnam 308
IT - Italia 293
DE - Germania 258
SE - Svezia 232
HK - Hong Kong 208
BR - Brasile 119
RU - Federazione Russa 114
IN - India 109
UA - Ucraina 105
IE - Irlanda 81
FR - Francia 77
NL - Olanda 75
CH - Svizzera 58
KR - Corea 49
CI - Costa d'Avorio 44
ZA - Sudafrica 42
EE - Estonia 37
FI - Finlandia 30
JP - Giappone 28
TG - Togo 28
BG - Bulgaria 24
AR - Argentina 21
AT - Austria 13
ES - Italia 11
ID - Indonesia 11
BE - Belgio 10
CA - Canada 10
HR - Croazia 10
SC - Seychelles 10
JO - Giordania 9
BD - Bangladesh 8
CZ - Repubblica Ceca 8
MX - Messico 8
GR - Grecia 7
EC - Ecuador 6
PL - Polonia 6
PT - Portogallo 5
TR - Turchia 5
AU - Australia 4
IR - Iran 4
LB - Libano 4
LT - Lituania 4
MA - Marocco 4
NG - Nigeria 4
PE - Perù 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
IQ - Iraq 3
UZ - Uzbekistan 3
BO - Bolivia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GA - Gabon 2
MD - Moldavia 2
PY - Paraguay 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DK - Danimarca 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
KH - Cambogia 1
NI - Nicaragua 1
NP - Nepal 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
YE - Yemen 1
Totale 7.202
Città #
Singapore 412
Southend 377
Fairfield 317
Chandler 316
Ashburn 295
Hong Kong 201
Santa Clara 195
Seattle 142
Woodbridge 142
Houston 134
Wilmington 125
Dong Ket 123
Cambridge 108
Hefei 102
Princeton 95
Dublin 81
Ann Arbor 78
Beijing 78
Boardman 63
Jacksonville 58
Bern 55
Seoul 49
Hanoi 47
Abidjan 44
Nanjing 43
Ho Chi Minh City 41
Los Angeles 41
Bologna 40
Westminster 39
Bremen 34
Padova 34
Dallas 29
Milan 29
New York 29
Lomé 28
Tokyo 28
Helsinki 26
San Diego 26
Sofia 24
Shenyang 23
Buffalo 22
Berlin 21
Jinan 21
Munich 21
Saint Petersburg 21
Florence 20
Nanchang 18
Turin 17
Redondo Beach 16
Tianjin 16
Medford 15
São Paulo 15
Changsha 14
Rome 14
Frankfurt am Main 13
Guangzhou 13
Hebei 13
Redwood City 13
Chicago 12
Des Moines 12
Bengaluru 11
Brussels 10
London 10
Amman 9
Dearborn 9
Kyiv 9
Mülheim 9
Haiphong 8
Ningbo 8
Nuremberg 8
Phoenix 8
Vienna 8
Atlanta 7
Denver 7
Falkenstein 7
Taiyuan 7
The Dalles 7
Düsseldorf 6
Kuban 6
Paris 6
Shanghai 6
Shijiazhuang 6
Xi'an 6
Amsterdam 5
Bühl 5
Hangzhou 5
Hải Dương 5
Jiaxing 5
Lauterbourg 5
Norwalk 5
Verona 5
Zhengzhou 5
Abeokuta 4
Brooklyn 4
Cala Millor 4
Charlotte 4
Fuzhou 4
Genoa 4
Haikou 4
Kunming 4
Totale 4.733
Nome #
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 221
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 218
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 214
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 199
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 179
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 178
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 169
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 166
Routine blood tests? Helping you live(r) longer! 164
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 163
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 160
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 158
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 157
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic eraThe views of a panel of worldwide international experts 156
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 155
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 154
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 149
Renovascular impedance correlates with portal pressure in patients with liver cirrhosis 147
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 146
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 143
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 143
Effetti dell’allenamento aerobico sui fattori di rischio cardiovascolare e sullo stato cognitivo dell’anziano 140
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 139
Systemic endothelial function evaluated by flow-mediated dilatation of brachial artery in patients with liver disease 136
Prevalence and factors associated with fatty liver in a geriatric population: results from the Pianoro Study. 135
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) 135
Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. 135
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 133
New abdominal collaterals at ultrasound: a clue of progression of portal hypertension 133
Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis 132
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis 131
Incidence and clinical implications of abstinence-induced hepatic recompensation in decompensated alcohol-related cirrhosis 130
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version) 127
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 125
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 121
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. 120
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS 119
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 117
null 115
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience 111
Natural history of formation and growth of oesophageal varices 107
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 102
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper 93
Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges 88
null 88
Torsade de pointes during amiodarone infusion in a cirrhotic patient with a prolonged QT interval. 87
Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of hematocrit and hepatic steatosis. 85
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 74
Splanchnic hemodynamics in non-alcoholic fatty liver disease: effect of a dietary/ pharmachological treatment. A pilot study 74
null 71
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 68
Inter‐Reader Agreement for Contrast‐Enhanced Ultrasound Liver Imaging Reporting and Data System Major Features and Final Categorization 62
Isolated hepatic tuberculoma after orthotopic liver transplantation: a case report 59
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 58
null 54
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part II 45
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part I 45
Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe 43
PREVENTION OF AGE-RELATED COGNITIVE DECLINE BY LONG TERM AEROBIC TRAINING 35
Totale 7.311
Categoria #
all - tutte 20.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021381 0 0 0 0 0 28 11 34 57 22 33 196
2021/2022858 74 23 40 44 78 48 23 48 34 46 251 149
2022/20231.085 116 164 68 162 59 79 31 57 165 21 81 82
2023/2024271 9 60 16 33 15 46 10 17 7 20 21 17
2024/20251.324 35 192 108 83 248 60 71 52 12 119 43 301
2025/20261.541 266 251 265 223 357 179 0 0 0 0 0 0
Totale 7.311